The share of US scientific publications in the world's top 10% cited in pulmonary and respiratory medicine is projected at 13.32% in 2024, decreasing gradually to 13.21% by 2028. This suggests a downward trend, with an average annual decrease of approximately 0.11% over these five years. Compared with recent years, this represents a continued slight decline observed from previous data in 2023.
Future trends to watch for include potential shifts in global research dynamics, investment in medical innovation within the US, and possible changes in publication and citation practices which could impact the share of top-cited US publications.
